Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin1.

BRIGHT publication

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300 U/ml) compared to degludec 100 U/ml in type 2 diabetes patients who had not previously received basal insulin1.

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

What's New in Pediatric Atopic Dermatitis?

What's New in Pediatric Atopic Dermatitis?

Real World Evidence Grafik Beyfortus®

Assessment of predictors for cancer-associated VTE recurrence after discontinuation of anticoagulant therapy: A multicenter cohort study

Plusprint RSV

Hội Thảo Khoa Học Bảo Vệ Khỏi Cúm Và Hơn Thế Nữa: Góc Nhìn Mới Trong Đánh Giá Vắc-xin Cúm Mùa